Contact and place of performance
Linda Smith
Colchester, VT 05446
USA
Title: Notice of Intent to Sole Source – REGARDS DNA Extraction and Quantification Notice ID: NIH-NOI-PCA-NIA-01601 Department/Ind. Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier: NATIONAL INSTITUTES OF HEALTH Office: NATIONAL INSTITUTE ON AGING Active Contract Opportunity Notice Type: Special Notice Original Published Date: June 11, 2026 Original Response Da...
View morePlace of Performance
Primary Place of Performance:
University of Vermont Laboratory for Clinical Biochemistry Research
Colchester Research Facility
360 South Park Drive, Room 224
Colchester, VT 05446
United States
Description
This is a Notice of Intent to Sole Source and is not a request for competitive proposals, quotations, or bids.
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Aging (NIA), Center for Alzheimer’s and Related Dementias (CARD), intends to negotiate and award a sole source firm-fixed-price contract to:
University of Vermont Laboratory for Clinical Biochemistry Research
Colchester Research Facility
360 South Park Drive, Room 224
Colchester, VT 05446
The purpose of this requirement is to obtain specialized laboratory support services for the Reasons for Geographic and Racial Difference in Stroke (REGARDS) project. The contractor shall perform DNA extraction, DNA quantification, repository handling, preparation, and shipment of extracted DNA samples for approximately 12,000 REGARDS participant biospecimens in support of a genome-wide association study (GWAS).
The contractor shall:
The anticipated period of performance is July 1, 2026 through June 30, 2029.
The statutory authority for this sole source acquisition is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.
The University of Vermont Laboratory for Clinical Biochemistry Research is the only known source capable of meeting the Government’s requirement because it designed and led the biosample collection effort for the REGARDS study, maintains the REGARDS biosample repository, serves as the REGARDS central analysis laboratory, and has custody of and access to the proprietary, unique, and non-replaceable REGARDS participant biospecimens required for this effort. Although other commercial laboratories may provide general DNA extraction and quantification services, no other source is known to possess the proprietary REGARDS starting samples or repository access required to perform this requirement.
This notice is not a solicitation. However, any responsible source that believes it is capable of meeting the Government’s requirement may submit a capability statement demonstrating its ability to satisfy the requirement described herein. Responses must clearly demonstrate the offeror’s capability to provide access to the proprietary REGARDS biospecimens and repository services, as well as the required DNA extraction, quantification, handling, and shipment services.
All capability statements received by the response date and time will be considered by the Government. A determination by the Government not to compete this proposed action based on responses to this notice is solely within the discretion of the Government.
No solicitation document is available. The Government will not reimburse respondents for any costs associated with submission of capability statements.
Attachments/Links
None at this time.
Contact Information
Primary Point of Contact
Linda Smith
Contracting Officer
[email protected]
Secondary Point of Contact
Danielle Tines
Procurement Technician
[email protected]
The National Institutes of Health (NIH), specifically the National Institute on Aging (NIA) and the Center for Alzheimer’s and Related Dementias (CARD), intends to award a sole-source, firm-fixed-price contract to the University of Vermont Laboratory for Clinical Biochemistry Research. This specialized laboratory support requirement facilitates the Reasons for Geographic and Racial Difference in Stroke (REGARDS) project. The contractor is tasked with performing DNA extraction, DNA quantification, repository handling, and shipment services for approximately 12,000 participant biospecimens to support a genome-wide association study. The University of Vermont is the designated source because it maintains the proprietary REGARDS biosample repository and possesses the unique, non-replaceable participant samples required for the project.
Under this requirement, the contractor will evaluate frozen packed cell availability, perform manual DNA extraction using the Qiagen Puregene DNA Purification Kit, and execute DNA quantification via PicoGreen. Additional responsibilities include maintaining a tracking inventory, preparing specific concentrations of DNA for shipment to CARD facilities, and identifying any failed extraction attempts. This effort is classified under NAICS 541380 for Testing Laboratories and Services and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.
The anticipated period of performance runs from July 1, 2026, through June 30, 2029. All work will be conducted at the Colchester, VT, facility. Although this is a notice of intent to sole source under the authority of 41 U.S.C. 3304(a)(1), the agency will consider capability statements from responsible sources submitted by the June 23, 2026, deadline. Two attachments, a Notice of Intent and a Statement of Work, were issued with the announcement under solicitation number NIH-NOI-PCA-NIA-01601.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.